Lab
Laboratorio Clinico Cuba, LLC
Laboratorio Clinico Cuba, LLC was paid $767K by Medicaid between Jan 2018 and Nov 2024, across 37 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 16% of everything it billed.
33Billing provider infoLABORATORIO CLINICO CUBA, LLC
MOCA, PR 00676
MOCA, PR 00676
33aNPI1720262728assigned 12/27/2007
33bProvider typeClinical Medical Laboratory
28Total paid$767K
24GClaims59,721
24DCodes billed37
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#170 of 777
Median peer was paid$278K
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,487 | $58K | |
| 2019 | 5,047 | $42K | |
| 2020 | 6,878 | $75K | |
| 2021 | 11,971 | $212K | |
| 2022 | 10,594 | $182K | |
| 2023 | 10,913 | $118K | |
| 2024incomplete | 7,831 | $81K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 16% | 3,123 | 2,643 | $126K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 13% | 4,587 | 3,641 | $99K |
| 84443 | Thyroid stimulating hormone (TSH) | 11% | 5,071 | 4,567 | $81K |
| 80061 | Lipid panel | 9.0% | 5,378 | 4,827 | $69K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.8% | 1,693 | 1,276 | $68K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.1% | 8,459 | 7,334 | $62K |
| 80053 | Comprehensive metabolic panel | 5.6% | 4,322 | 3,854 | $43K |
| 82274 | 3.8% | 1,863 | 1,680 | $29K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.3% | 909 | 833 | $25K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.1% | 2,519 | 2,314 | $24K |
| 81000 | 2.5% | 6,167 | 5,460 | $19K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.3% | 2,185 | 1,968 | $18K |
25 more codes
| 86328 | 1.8% | 934 | $14K | |
| 84153 | 1.8% | 750 | $14K | |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 3,699 | $12K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 925 | $11K |
| 82043 | 1.3% | 1,727 | $10K | |
| 82570 | 1.2% | 1,894 | $10K | |
| 86738 | <1% | 554 | $8K | |
| 87088 | <1% | 529 | $4K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 454 | $4K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 65 | $3K |
| 82607 | <1% | 169 | $3K | |
| 84439 | <1% | 230 | $2K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 80 | $2K |
| 86592 | <1% | 391 | $2K | |
| 86701 | <1% | 189 | $1K | |
| 81001 | <1% | 378 | $1K | |
| 86703 | <1% | 73 | $883.21 | |
| 87276 | <1% | 73 | $801.28 | |
| 87275 | <1% | 73 | $791.49 | |
| 85651 | <1% | 114 | $372.62 | |
| 85730 | <1% | 50 | $284.99 | |
| 85610 | <1% | 39 | $135.59 | |
| 85004 | <1% | 15 | $97.05 | |
| 82947 | <1% | 28 | $93.78 | |
| 84436 | <1% | 12 | $75.26 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGONZALEZ, ZENAIDA (PERSONA AUTORIZADA)